Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2014

Open Access 01-12-2014 | Study protocol

Improving the retention rate for residential treatment of substance abuse by sequential intervention for social anxiety

Authors: Petra K Staiger, Michael Kyrios, James S Williams, Nicolas Kambouropoulos, Alexandra Howard, Stefan Gruenert

Published in: BMC Psychiatry | Issue 1/2014

Login to get access

Abstract

Background

Residential drug rehabilitation is often seen as a treatment of last resort for people with severe substance abuse issues. These clients present with more severe symptoms, and frequent psychiatric comorbidities relative to outpatients. Given the complex nature of this client group, a high proportion of clients seeking treatment often do not enter treatment, and of those who do, many exit prematurely. Given the highly social nature of residential drug rehabilitation services, it has been argued that social anxieties might decrease the likelihood of an individual entering treatment, or increase the likelihood of them prematurely exiting treatment. The current paper reports on the protocol of a Randomised Control Trial which examined whether treatment of social anxiety prior to entry to treatment improves entry rates and retention in residential drug rehabilitation.

Method/design

A Randomised Control Trial comparing a social skills treatment with a treatment as usual control group was employed. The social skills training program was based on the principles of Cognitive Behaviour Therapy, and was adapted from Ron Rapee’s social skills training program. A permutated block randomisation procedure was utilised. Participants are followed up at the completion of the program (or baseline plus six weeks for controls) and at three months following entry into residential rehabilitation (or six months post-baseline for participants who do not enter treatment).

Discussion

The current study could potentially have implications for addressing social anxiety within residential drug treatment services in order to improve entry and retention in treatment. The results might suggest that the use of additional screening tools in intake assessments, a focus on coping with social anxieties in support groups for clients waiting to enter treatment, and greater awareness of social anxiety issues is warranted.

Australian New Zealand clinical trials registry

Australian New Zealand Clinical Trials Registry (ACTRN) registration number: ACTRN12611000579​998
Appendix
Available only for authorised users
Literature
1.
Vergara-Moragues E, González-Saiz F, Lozano OM, García AV: Psychiatric profile of three-month retention in cocaine- dependent patients treated in a therapeutic community. J Stud Alcohol Drugs. 2013, 74 (3): 452-459.CrossRefPubMed
2.
Astals M, Díaz L, Domingo-Salvany A, Martín-Santos R, Bulbena A, Torrens M: Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: an 18-month follow-up study. Int J Environ Res Publ Health. 2009, 6 (11): 2822-2832. 10.3390/ijerph6112822.CrossRef
3.
Fowler JC, Groat M, Ulanday M: Attachment style and treatment completion among psychiatric inpatients with substance use disorders. Am J Addict. 2013, 22 (1): 14-17. 10.1111/j.1521-0391.2013.00318.x.CrossRefPubMed
4.
Stark MJ: Dropping out of substance abuse treatment: a clinically oriented review. Clin Psychol Rev. 1992, 12 (1): 93-116. 10.1016/0272-7358(92)90092-M.CrossRef
5.
Randall CL, Thomas S, Thevos AK: Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol Clin Exp Res. 2001, 25 (2): 210-220. 10.1111/j.1530-0277.2001.tb02201.x.CrossRefPubMed
6.
Etheridge RM, Hubbard RL, Anderson J, Craddock SG, Flynn PM: Treatment structure and program services in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav. 1997, 11 (4): 244-260.CrossRef
7.
De Leon G: Chapter 66 - therapeutic communities. Interventions for Addiction. Edited by: Peter MM. 2013, San Diego: Academic, 643-653.CrossRef
8.
Budde D, Rounsaville B, Bryant K: Inpatient and outpatient cocaine abusers: clinical comparisons at intake and one-year follow-up. J Subst Abuse Treat. 1992, 9 (4): 337-342. 10.1016/0740-5472(92)90028-M.CrossRefPubMed
9.
Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, Cooke R: The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS). Drug Alcohol Rev. 2005, 24 (5): 411-418. 10.1080/09595230500286039.CrossRefPubMed
10.
Eland-Goossensen A, van de Goor IAM, Garretsen HFL: Heroin addicts in the community and in treatment compared for severity of problems and need for help. Subst Use Misuse. 1997, 32 (10): 1313-1330. 10.3109/10826089709039380.CrossRefPubMed
11.
Ross S, Dermatis H, Levounis P, Galanter M: A comparison between dually diagnosed inpatients with and without Axis II comorbidity and the relationship to treatment outcome. Am J Drug Alcohol Abuse. 2003, 29 (2): 263-279. 10.1081/ADA-120020511.CrossRefPubMed
12.
Weinstock J, Alessi SM, Petry NM: Regardless of psychiatric severity the addition of contingency management to standard treatment improves retention and drug use outcomes. Drug Alcohol Depend. 2007, 87 (2–3): 288-296.CrossRefPubMed
13.
Polimeni A-M, Moore S, Gruenert S: MMPI-2 profiles of clients with substance dependencies accessing a therapeutic community treatment facility Electronic. J Appl Psychol. 2010, 6 (1): 1-9.
14.
Australian Institute of Health and Welfare Canberra: Alcohol and other drug treatment services in Australia 2011–12. Drug treatment series 21 Cat no HSE139. 2013, Canberra: AIHW
15.
Johns K, Baker A, Webster RA, Lewin TJ: Factors associated with retention in a long-term residential rehabilitation programme for women with substance use problems. Ment Health Subst Use Dual Diagn. 2009, 2 (1): 40-51. 10.1080/17523280802593285.CrossRef
16.
Mandell W, Edelen MO, Wenzel SL, Dahl J, Ebener P: Do dimensions of therapeutic community treatment predict retention and outcomes?. J Subst Abuse Treat. 2008, 35 (3): 223-231. 10.1016/j.jsat.2007.10.004.CrossRefPubMedPubMedCentral
17.
De Leon G: Is the therapeutic community an evidence-based treatment? What the evidence says. Ther Communities. 2010, 31 (2): 104-128.
18.
Vanderplasschen W, Colpaert K, Autrique M, Rapp RC, Pearce S, Broekaert E, Vandevelde S: Therapeutic communities for addictions: a review of their effectiveness from a recovery-oriented perspective. Sci World J. 2013, 2013: 427817-
19.
Darke S, Ross J, Teesson M: The Australian treatment outcome study (ATOS): what have we learnt about treatment for heroin dependence?. Drug Alcohol Rev. 2007, 26 (1): 49-54. 10.1080/09595230601036986.CrossRefPubMed
20.
Simpson DD, Joe GW, Broome KM, Hiller ML, Knight K, Rowan-Szal GA: Program diversity and treatment retention rates in the drug abuse treatment outcome study (DATOS). Psychol Addict Behav. 1997, 11 (4): 279-293.CrossRef
21.
Simpson DD, Joe GW, Rowan-Szal GA: Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend. 1997, 47 (3): 227-235. 10.1016/S0376-8716(97)00099-9.CrossRefPubMed
22.
Zhang Z, Friedmann PD, Gerstein DR: Does retention matter? Treatment duration and improvement in drug use. Addiction. 2003, 98 (5): 673-684. 10.1046/j.1360-0443.2003.00354.x.CrossRefPubMed
23.
Condelli WS, De Leon G: Fixed and dynamic predictors of client retention in therapeutic communities. J Subst Abuse Treat. 1993, 10 (1): 11-16. 10.1016/0740-5472(93)90093-H.CrossRefPubMed
24.
Buckner JD, Heimberg RG, Ecker AH, Vinci C: A biopsychosocial model of social anxiety and substance use. Depress Anxiety. 2013, 30 (3): 276-284. 10.1002/da.22032.CrossRefPubMed
25.
Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S: Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking. Drug Alcohol Depend. 2005, 78 (3): 309-315. 10.1016/j.drugalcdep.2004.12.001.CrossRefPubMed
26.
Brunello N, den Boer JA, Judd LL, Kasper S, Kelsey JE, Lader M, Lecrubier Y, Lepine JP, Lydiard RB, Mendlewicz J, et al: Social phobia: diagnosis and epidemiology, neurobiology and pharmacology, comorbidity and treatment. J Affect Disord. 2000, 60 (1): 61-74. 10.1016/S0165-0327(99)00140-8.CrossRefPubMed
27.
World Health Organization: The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. 1992, Geneva: World Health Organization
28.
Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC: Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch Gen Psychiatr. 1997, 54 (4): 313-321. 10.1001/archpsyc.1997.01830160031005.CrossRefPubMed
29.
Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ: The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. Am J Orthopsychiatry. 1996, 66 (1): 17-31.CrossRefPubMed
30.
Teesson M, Hall W, Lynskey M, Degenhardt L: Alcohol- and drug-use disorders in Australia: implications of the national survey of mental health and wellbeing. Aust N Z J Psychiatr. 2000, 34 (2): 206-213. 10.1080/j.1440-1614.2000.00715.x.CrossRef
31.
Bakken K, Landheim AS, Vaglum P: Substance-dependent patients with and without social anxiety disorder: occurrence and clinical differences: a study of a consecutive sample of alcohol-dependent and poly-substance-dependent patients treated in two counties in Norway. Drug Alcohol Depend. 2005, 80 (3): 321-328. 10.1016/j.drugalcdep.2005.04.011.CrossRefPubMed
32.
Kushner MG, Sher KJ, Beitman BD: The relation between alcohol problems and the anxiety disorders. Am J Psychiatr. 1990, 147 (6): 685-695.CrossRefPubMed
33.
Book SW, Randall CL: Social anxiety disorder and alcohol use. Alcohol Res Health. 2002, 26 (2): 130-135.
34.
Havard A, Teesson M, Darke S, Ross J: Depression among heroin users: 12-Month outcomes from the Australian treatment outcome study (ATOS). J Subst Abuse Treat. 2006, 30 (4): 355-362. 10.1016/j.jsat.2006.03.012.CrossRefPubMed
35.
Liappas J, Paparrigopoulos T, Tzavellas E, Christodoulou G: Alcohol detoxification and social anxiety symptoms: a preliminary study of the impact of mirtazapine administration. J Affect Disord. 2003, 76 (1–3): 279-284.CrossRefPubMed
36.
Litman GK, Eiser JR, Rawson NSB, Oppenheim AN: Differences in relapse precipitants and coping behaviour between alcohol relapsers and survivors. Behav Res Ther. 1979, 17 (2): 89-94. 10.1016/0005-7967(79)90016-0.CrossRefPubMed
37.
McNeil DW: Terminology and evolution of constructs in social anxiety and social phobia. From social anxiety to social phobia: Multiple perspectives. Edited by: Hofmann SG, DiBartolo PM, Needham H. 2001, MA US: Allyn & Bacon, 8-19.
38.
Stein MB, Torgrud LJ, Walker JR: Social phobia symptoms, subtypes, and severity: findings from a community survey. Arch Gen Psychiatr. 2000, 57 (11): 1046-1052. 10.1001/archpsyc.57.11.1046.CrossRefPubMed
39.
Vriends N, Becker ES, Meyer A, Michael T, Margraf J: Subtypes of social phobia: are they of any use?. J Anxiety Disord. 2007, 21 (1): 59-75. 10.1016/j.janxdis.2006.05.002.CrossRefPubMed
40.
Ruscio AM: The latent structure of social anxiety disorder: consequences of shifting to a dimensional diagnosis. J Abnorm Psychol. 2010, 119 (4): 662-671.CrossRefPubMedPubMedCentral
41.
Crome E, Baillie A, Slade T, Ruscio AM: Social phobia: further evidence of dimensional structure. Aust New Zealand J Psychiatr. 2010, 44 (11): 1012-1020.
42.
Kollman DM, Brown TA, Liverant GI, Hofmann SG: A taxometric investigation of the latent structure of social anxiety disorder in outpatients with anxiety and mood disorders. Depress Anxiety. 2006, 23 (4): 190-199. 10.1002/da.20158.CrossRefPubMed
43.
Crum RM, Pratt LA: Risk of heavy drinking and alcohol use disorders in social phobia: a prospective analysis. Am J Psychiatr. 2001, 158 (10): 1693-1700. 10.1176/appi.ajp.158.10.1693.CrossRefPubMed
44.
Weeks JW, Carleton RN, Asmundson GJG, McCabe RE, Antony MM: "Social Anxiety Disorder Carved at its Joints": evidence for the taxonicity of social anxiety disorder. J Anxiety Disord. 2010, 24 (7): 734-742. 10.1016/j.janxdis.2010.05.006.CrossRefPubMed
45.
El-Sayegh S, Fattal O, Muzina DJ: Is social anxiety disorder unrecognized in patients with substance dependence?. Addict Dis Their Treat. 2006, 5 (3): 145-151. 10.1097/01.adt.0000210714.87821.98.CrossRef
46.
Terra MB, Barros HMT, Stein AT, Figueira I, Athayde LD, Spanemberg L, De Aguiar PM, Filho LD, Da Silveira DX: Does co-occurring social phobia interfere with alcoholism treatment adherence and relapse?. J Subst Abuse Treat. 2006, 31 (4): 403-409. 10.1016/j.jsat.2006.05.013.CrossRefPubMed
47.
Wyman K, Castle DJ: Anxiety and substance use disorder comorbidity: prevalence, explanatory models and treatment implications. J Dual Diagn. 2006, 2 (4): 93-119. 10.1300/J374v02n04_07.CrossRef
48.
Schadé A, Marquenie LA, van Balkom AJLM, Koeter MWJ, de Beurs E, van den Brink W, van Dyck R: The effectiveness of anxiety treatment on alcohol-dependent patients with a comorbid phobic disorder: a randomized controlled trial. Alcohol Clin Exp Res. 2005, 29 (5): 794-800. 10.1097/01.ALC.0000163511.24583.33.CrossRefPubMed
49.
Baillie AJ, Sannibale C, Stapinski LA, Teesson M, Rapee RM, Haber PS: An investigator-blinded, randomized study to compare the efficacy of combined CBT for alcohol use disorders and social anxiety disorder versus CBT focused on alcohol alone in adults with comorbid disorders: The Combined Alcohol Social Phobia (CASP) trial protocol. BMC Psychiatr. 2013, 13: 199-10.1186/1471-244X-13-199.CrossRef
50.
Moher D, Schulz KF, Altman DG: The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet. 2001, 357 (9263): 1191-1194. 10.1016/S0140-6736(00)04337-3.CrossRefPubMed
51.
Rapee RM: Overcoming shyness and social phobia: a step by step guide. 1998, : Jason Aronson, Inc
52.
Rapee RM, Abbott MJ, Baillie AJ, Gaston JE: Treatment of social phobia through pure self-help and therapist-augmented self-help. Br J Psychiatr. 2007, 191 (3): 246-252. 10.1192/bjp.bp.106.028167.CrossRef
53.
Wilson JK, Rapee RM: The interpretation of negative social events in social phobia: changes during treatment and relationship to outcome. Behav Res Ther. 2005, 43 (3): 373-389. 10.1016/j.brat.2004.02.006.CrossRefPubMed
54.
Liebowitz MR: Social phobia. Mod Probl Pharmacopsychiatr. 1987, 22: 141-173.CrossRef
55.
American Psychiatric Association: Diagnostic & statistical manual of mental disorders: DSM-IV-TR. 2000, Washington, D.C: American Psychiatric Association, 4
56.
Merikangas KR, Avenevoli S, Acharyya S, Zhang H, Angst J: The spectrum of social phobia in the zurich cohort study of young adults. Biol Psychiatr. 2002, 51 (1): 81-91. 10.1016/S0006-3223(01)01309-9.CrossRef
57.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC: The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatr. 1998, 59 (SUPPL. 20): 22-33.
58.
Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, Janavs J, Dunbar GC: The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur Psychiatr. 1997, 12 (5): 224-231. 10.1016/S0924-9338(97)83296-8.CrossRef
59.
W.H.O. Assist Working Group: The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002, 97 (9): 1183-1194. 10.1046/j.1360-0443.2002.00185.x.CrossRef
60.
Newcombe DAL, Humeniuk RE, Ali R: Validation of the World Health Organization Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): report of results from the Australian site. Drug Alcohol Rev. 2005, 24 (3): 217-226. 10.1080/09595230500170266.CrossRefPubMed
61.
Sobell LC, Sobell MB: Timeline Follow-Back: A technique for assessing self-reported ethanol consumption. Measuring Alcohol Consumption: Psychosocial and Biological Methods. Edited by: Allen J, Litten RZ. 1992, NJ: Humana Press, 41-72.CrossRef
62.
Douglas SM, Fresco DM, Heimberg RG, Schneier FR, Davies SO, Liebowitz MR: Screening for social anxiety disorder in the clinical setting: using the leibowitz social anxiety scale. Anxiety Disord. 2002, 16: 661-673. 10.1016/S0887-6185(02)00134-2.CrossRef
63.
Heimberg RG, Horner KJ, Juster HR, Safren SA, Brown EJ, Schneier FR, Liebowitz MR: Psychometric properties of the Liebowitz Social Anxiety Scale. Psychol Med. 1999, 29 (01): 199-212. 10.1017/S0033291798007879.CrossRefPubMed
64.
Fresco DM, Coles ME, Heimberg RG, Liebowitz MR, Hami S, Stein MB, Goetz D: The Liebowitz Social Anxiety Scale: a comparison of the psychometric properties of self-report and clinician-administered formats. Psychol Med. 2001, 31 (06): 1025-1035.CrossRefPubMed
65.
Beck AT, Epstein N, Brown G, Steer RA: An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988, 56 (6): 893-897.CrossRefPubMed
66.
Beck AT, Steer RA, Brown G: Manual for the Beck Depression Inventory-II. 1996, TX: Psychological Corporation
67.
Beck AT, Steer RA, Ball R, Ranieri WF: Comparison of beck depression inventories-IA and-II in psychiatric outpatients. J Pers Assess. 1996, 67 (3): 588-597. 10.1207/s15327752jpa6703_13.CrossRefPubMed
68.
De Leon G, Melnick G, Kressel D, Jainchill N: Circumstances, motivation, readiness, and suitability (the CMRS scales): predicting retention in therapeutic community treatment. Am J Drug Alcohol Abuse. 1994, 20 (4): 495-515. 10.3109/00952999409109186.CrossRefPubMed
69.
Attkisson CC, Greenfield TK: Client Satisfaction Questionnaire-8 and Service Satisfaction Scale-30. The use of psychological testing for treatment planning and outcome assessment. 1994, Hillsdale, NJ, England: Lawrence Erlbaum Associates, Inc, 402-420.
70.
Staiger P, Lake A, Long C: Preventing Relapse: A Responsible Drinking Program for Recovering Drug Users. 2011, Melbourne, Australia: Deakin University
71.
Simpson DD, Joe GW: A longitudinal evaluation of treatment engagement and recovery stages. J Subst Abuse Treat. 2004, 27 (2): 89-97. 10.1016/j.jsat.2004.03.001.CrossRefPubMed
Metadata
Title
Improving the retention rate for residential treatment of substance abuse by sequential intervention for social anxiety
Authors
Petra K Staiger
Michael Kyrios
James S Williams
Nicolas Kambouropoulos
Alexandra Howard
Stefan Gruenert
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2014
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-14-43

Other articles of this Issue 1/2014

BMC Psychiatry 1/2014 Go to the issue

Research article

More rumination and less effective emotion regulation in previously depressed women with preserved executive functions

Research article

Examining the feasibility of an economic analysis of dyadic developmental psychotherapy for children with maltreatment associated psychiatric problems in the United Kingdom

Study protocol

Money for medication: a randomized controlled study on the effectiveness of financial incentives to improve medication adherence in patients with psychotic disorders

Study protocol

Study Protocol for a randomized controlled trial of mentalization based therapy against specialist supportive clinical management in patients with both eating disorders and symptoms of borderline personality disorder

Research article

Suicide and suicide attempts in people with severe mental disorders in Butajira, Ethiopia: 10 year follow-up of a population-based cohort

Research article

Development and evaluation of culturally sensitive psychosocial interventions for under-served people in primary care